Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Estimated Industry Valuation for the Life Science Tools Sector?
The market size for life science tools has seen a swift expansion in the recent past. The market is projected to escalate from $176.74 billion in 2024 to $201.37 billion in 2025, with a compound annual growth rate (CAGR) of 13.9%. Factors such as the increasing incidence of chronic and infectious diseases, augmented production volumes within the pharmaceutical and biotech sectors, a rise in the demand for clinical diagnostic testing, the expansion of environmental and food safety testing, and the enhanced incorporation of automation in laboratory procedures have contributed to this historical period’s growth.
Expectations point to the life science tools market expanding rapidly over the coming years, reaching a market size of $335.13 billion in 2029 with a compound annual growth rate (CAGR) of 13.6%. This predicted uptick during the forecast period derives from the growing demand for tools tailored to the development of personalized treatments, the broadening of cell and gene therapy manufacturing capabilities, a surge in the requirement for high-purity reagents in industrial sectors, the rise in the adoption of decentralized diagnostic testing, and an upturn in the production of biologics and biosimilars. The period is also set to see trends such as the widespread use of cloud-based platforms for managing laboratory data, a movement towards integrating multi-omics in research, the application of cryo-electron microscopy for high-resolution imaging, tailoring of lab instruments for specialized research fields, and increased usage of lab-on-a-chip and microfluidic technologies.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=27329&type=smp
What Forces Are Driving The Growth Of The Life Science Tools Market?
Increased interest in biopharmaceuticals is projected to spur the expansion of the life science tools market in the future. Biopharmaceuticals, medical drugs developed using biotechnology, employ biological elements like living cells or organisms to produce various therapies like proteins, antibodies, or vaccines. The popularity of biopharmaceuticals is mainly attributed to their effectiveness in dealing with serious and chronic illnesses that conventional small-molecule pharmaceuticals fail to sufficiently combat. Life science tools facilitate the production and elaboration of biopharmaceuticals, offering indispensable technology for research, examination, and quality assurance throughout the drug’s manufacturing process, thus securing precision, effectiveness, and adherence to regulation policies. To exemplify, Cardinal Health Inc., a healthcare firm based in the US, revealed in January 2023 that 33 biosimilar products had received FDA approval in the US as of January 2022, with 21 available in the market. By 2023, the number of FDA-authorized biosimilars had escalated to 40, with 25 available for commercial purchase. Hence, the escalating demand for biopharmaceuticals is fuelling the growth of the life science tools market.
How Is The Life Science Tools Industry Segmented Across Key Parameters?
The life science tools market covered in this report is segmented
1) By Type: Instruments, Consumables, Services
2) By Technology: Polymerase Chain Reaction(PCR) And Quantitative Polymerase Chain Reaction (qPCR), Sanger Sequencing, Separation Technologies, Flow Cytometry, Nucleic Acid Microarray, Mass Spectrometry, Other Technologies
3) By Application: Drug Discovery And Development, Clinical Diagnostics, Genomic And Proteomic Research, Cell Biology Research, Other Applications
4) By End-User: Academic And Research Institutions, Biotechnology And Pharmaceutical Companies, Hospitals And Diagnostic Laboratories, Contract Research Organizations (CROs), Government And Regulatory Agencies
Subsegments:
1) By Instruments: Microscopes, Sequencers, Analyzers, Spectrometers, Centrifuges, Chromatography Systems, Laboratory Automation Equipment
2) By Consumables: Reagents, Kits, Culture Media, Pipettes And Tips, Plasticware, Laboratory Chemicals, Assay Kits
3) By Services: Calibration Services, Maintenance And Repair, Laboratory Testing Services, Consulting Services, Training And Support, Research And Development Services
What Notable Trends Are Shaping The Direction Of The Life Science Tools Market?
The companies leading the life science tools market are prioritizing the creation of groundbreaking solutions such as automated sequencing platforms. These innovative tools are designed to bolster efficiency, precision, and access in genetic analysis, thereby speeding up both research and clinical diagnostics. Automated sequencing platforms represent state-of-the-art systems capable of executing DNA or RNA sequencing with limited human input, via the use of robotics and software. This facilitates the expansion of throughput, the minimization of errors and the provision of faster, more dependable genetic research and diagnostics. A compelling example is the launch of the MiSeq i100 series by Illumina Inc., a biotechnology company based in the US, in October 2024. The series signifies the company’s quickest and most straightforward benchtop sequencers aimed at broadening the availability of next-generation sequencing to a larger variety of labs. Both the MiSeq i100 and MiSeq i100 Plus Systems present the advantage of room-temperature kit storage and shipping, sidestepping any potential delays caused by reagent thawing and permitting sample-to-analysis workflows on the same day. Boasting rapid sequencing with run times of just four hours, affordable consumables, and easy-to-use, push-button workflows that play a part in numerous applications across microbiology, infectious disease, and oncology, these platforms demonstrate the market’s inclination towards efficient, scalable, and simple sequencing tools that aid researchers and clinicians.
Which Companies Currently Dominate The Competitive Landscape In The Life Science Tools Industry?
Major companies operating in the life science tools market are F. Hoffmann-La Roche Ltd., Merck KGaA, Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., Lonza Group Ltd., Illumina Inc., Sartorius AG, Shimadzu Corporation, Revvity Inc., Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Eppendorf AG, Tecan Group Ltd., Bio-Techne Corporation, Takara Bio Inc., GenScript Biotech Corporation, 10x Genomics Inc., and Hamilton Company.
Get The Full Report Here:
https://www.thebusinessresearchcompany.com/report/life-science-tools-global-market-report
Which Geographic Regions Are Driving Demand In The Life Science Tools Market?
North America was the largest region in the life science tools market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the life science tools market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/customise?id=27329&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model